In order to test our hypothesis this study utilized two well-known potent transgenic models of breast cancer, the FVB/N-Tg (MMTV-PyVT)634Mul/J and the FVB-Tg (MMTV-ErbB2) NK1Mul/J [21–23]. This evidence concerns the gene ERBB2 and breast carcinoma.